Cargando…
Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction
Diabetic retinopathy (DR) is a well-known microvascular complication related to inflammation. Mcc950 is a potent and specific inhibitor of the NLRP3 inflammasome but its influence on DR has not been studied. Thus, we evaluated the anti-inflammatory effects of Mcc950 on high-glucose-induced human ret...
Autores principales: | Zhang, Yi, Lv, Xuehua, Hu, Zizhong, Ye, Xiaojian, Zheng, Xinhua, Ding, Yuzhi, Xie, Ping, Liu, Qinghuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550855/ https://www.ncbi.nlm.nih.gov/pubmed/28726778 http://dx.doi.org/10.1038/cddis.2017.308 |
Ejemplares similares
-
MCC950, the NLRP3 Inhibitor, Protects against Cartilage Degradation in a Mouse Model of Osteoarthritis
por: Ni, Bowei, et al.
Publicado: (2021) -
MCC950 closes the active conformation of NLRP3 to an inactive
state
por: Tapia-Abellán, Ana, et al.
Publicado: (2019) -
MCC950 ameliorates ventricular arrhythmia vulnerability induced by heart failure
por: Jiang, Xiaobo, et al.
Publicado: (2022) -
Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice
por: Zhai, Yadong, et al.
Publicado: (2018) -
Inhibiting the inflammasome with MCC950 counteracts muscle pyroptosis and improves Duchenne muscular dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)